PTPDC1

Model summary

A soluble human phosphatase that employs a cysteine-dependent catalytic core to remove phosphate groups from protein substrates and assemble transient regulatory complexes. By shuttling between the nucleoplasm and ciliary-associated signaling hubs, it tunes Smoothened-dependent pathways and supports assembly of the primary cilium. Its activity likely coordinates phosphorylation states of signaling and transport machinery in the cilium while modulating transcriptional and chromatin-associated regulators in the nucleus, thereby coupling ciliary state to nuclear responses.

Predicted Gene Ontology terms

1. 01

   I begin by dissecting the InterPro architecture and its order along the sequence.

   A broad scaffold of PTP-related signatures spans the core of the protein: IPR029021 (Protein-tyrosine phosphatase-like homologous superfamily, residues 79–248) and IPR050561 (Protein Tyrosine Phosphatase family, residues 36–716) define a classical cysteine-dependent phosphatase fold and family membership across most of the polypeptide. Nested within this scaffold is a tightly focused catalytic module: IPR049573 (Protein tyrosine phosphatase domain-containing protein 1, PTP domain, residues 76–280) encompasses the enzymatic core; IPR020422 (Dual specificity protein phosphatase domain, residues 82–253) and IPR000340 (Dual specificity phosphatase catalytic domain, residues 165–235) specify a dual-specificity configuration capable of acting on phosphotyrosine as well as phosphoserine/threonine; IPR003595 (Protein-tyrosine phosphatase, catalytic domain, residues 150–243) and IPR000387 (Tyrosine-specific protein phosphatases domain, residues 168–235) pinpoint the canonical PTP catalytic machinery; and IPR016130 (Protein-tyrosine phosphatase, active site, residues 188–198) marks the essential nucleophilic cysteine-centered motif that drives catalysis. The ordered nesting of these domains—family-wide envelope (36–716), PTP-like core (79–248), and the catalytic heart (150–243 with the 188–198 active site)—causally establishes a cysteine-dependent phosphatase that hydrolyzes phosphomonoesters on protein substrates.

2. 02

   This catalytic architecture dictates molecular function.

   The presence of the canonical PTP active site (IPR016130) and dual-specificity hallmarks (IPR020422/IPR000340) causes phosphatase activity that can act on phosphotyrosine and potentially phosphoserine/threonine residues. Such enzymes typically operate through transient complex formation with substrates and adaptors, which necessitates multivalent contacts consistent with GO:0005515 protein binding. The breadth of the PTP-like superfamily and the extended family footprint (36–716) further supports a soluble, scaffolded enzyme that relies on protein–protein interfaces to recruit targets.

3. 03

   From this catalytic base, I infer the biological processes it influences.

   A dual-specificity PTP often tunes signaling pathways by dephosphorylating pathway nodes. The explicit processes implicated here are the smoothened signaling pathway (GO:0007224) and cilium assembly (GO:0060271). The causal link is that Smoothened-dependent Hedgehog signaling is transduced within the primary cilium, and cilium biogenesis depends on tightly regulated phosphorylation states of intraflagellar transport components and associated signaling assemblies. A soluble nuclear/ciliary-enriched PTP that can dephosphorylate pathway components provides a mechanistic route to modulate both Smoothened signaling and ciliogenesis.

4. 04

   Cellular localization follows from both the soluble catalytic architecture and the provided compartmental cues.

   The absence of transmembrane segments and the soluble PTP fold argue for a non-membranous localization. The experimentally supported nucleoplasmic residence aligns with GO:0005654 nucleoplasm and the broader nuclear designation. A nuclear/nucleoplasmic pool of a soluble PTP can regulate transcriptional outputs downstream of ciliary and Smoothened signals by dephosphorylating transcriptional regulators or chromatin-associated factors, thereby bridging nuclear signaling to ciliary assembly states.

5. 05

   Integrating these lines of evidence yields a mechanistic hypothesis.

   The enzyme’s PTP catalytic core (150–243 with the 188–198 nucleophile motif) dephosphorylates signaling nodes that shuttle between the cilium and nucleus. In the cilium, it likely tunes phosphorylation of Smoothened pathway components and intraflagellar transport machinery to control cilium assembly. In the nucleoplasm, it modulates transcriptional programs and chromatin-associated complexes downstream of Smoothened signaling. This shuttling, scaffolded phosphatase uses protein-binding interfaces to assemble transient complexes, thereby exerting precise control over ciliary assembly and Smoothened pathway throughput.

6. 06

   From this model, I hypothesize interaction partners that fit the pathway and compartment: Smoothened receptor complexes and their nuclear effectors; ciliary assembly factors such as IFT-B and IFT-A subunits; transition zone scaffolds that gate ciliary entry; and nuclear transcriptional regulators and chromatin modifiers that interpret Hedgehog/ciliary cues.

   These assemblies would allow the enzyme to couple nucleoplasmic signaling with ciliary state via reversible phosphorylation.